Skip to content

Transition to Ambulatory Bariatric Surgery (TABS) Trial

Transition to Ambulatory Bariatric Surgery (TABS) Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07011628
Acronym
TABS
Enrollment
200
Registered
2025-06-09
Start date
2026-10-01
Completion date
2028-05-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery, Obesity and Obesity-related Medical Conditions

Keywords

ambulatory surgery, same day discharge, gastric bypass, sleeve gastrectomy

Brief summary

This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.

Detailed description

This pragmatic, parallel, randomized, open-label trial aims to determine the safety and feasibility of same day discharge (SDD) for bariatric surgery including sleeve gastrectomy and gastric bypass. Investigators will investigate the frequency of 7-day emergency department visits with SDD after bariatric surgery (Aim 1). In addition, the investigators will compare total 30-day charges between participants who undergo same day discharge versus those receive post-operative hospital admission (Aim 2).

Interventions

Patients in the same day discharge arm will be discharged from the hospital within 6 hours of arriving to the recovery unit and without an overnight stay in the hospital.

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* BMI ≤ 60 kg/m2 * Primary Sleeve gastrectomy or Gastric Bypass, * Undergoing bariatric surgery at sponsor site

Exclusion criteria

* Type 1 Diabetes * Myocardial Infarction * Unstable Angina or Heart Failure * Prior Stroke * Solid organ transplantation * Systemic glucocorticoid prior 28 days * Severe Obstructive Sleep Apnea * Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90) * Untreated Hyperthyroidism * Chronic Kidney Disease (EGFR \< 60) * Current anticoagulant use, * Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%) * Chronic opioid use * Insulin dependence. * Need for extended venous thromboembolic event prophylaxis, * \> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery) * Patient lives \> 130 miles from the hospital. * Tobacco use in last 12 months * Desire to become pregnant or active pregnancy * Prisoners * Unable or unwilling to follow-up * Unable to understand or provide consent

Design outcomes

Primary

MeasureTime frameDescription
Emergency Department Visitsbaseline to seven daysNumber of emergency room visits after surgery

Secondary

MeasureTime frameDescription
Readmissions to the hospitalbaseline to 30 daysStudy personnel will investigate the incidence of readmissions to the hospital in the post-surgical period.
The number of operations or proceduresbaseline to 30 daysStudy personnel will compare the frequency of reoperations and procedural interventions after surgery

Countries

United States

Contacts

CONTACTJason Samuels
jason.m.samuels@vumc.org(615) 322 - 4504

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026